Lung Cancer Stage 4 Doctors in Turkey — Page 2

Associate Professor Yusuf Acikgoz recently sharpened his oncology expertise at Ohio State University – one of the leading cancer research centres in the United States.

• Specialises in immunotherapy and novel drug treatments for advanced lung cancer
• Served as assistant investigator for global Phase III clinical trials
• Completed immuno-oncology training through the Central European Cooperative Oncology Group
• Member of the American Society of Clinical Oncology (ASCO)
• Practises at Lokman Hekim University – a top-tier Turkish teaching hospital

Professor Cemil Bilir is a specialist medical oncologist at VM Medical Park Pendik with extensive international training from the Cleveland Clinic.

• Completed a research fellowship at Northeastern University in Boston focusing on biotechnology and nanomedicine
• Focuses on advanced-stage cancer management using evidence-based protocols from the latest clinical research
• Maintains active membership in the American Society of Clinical Oncology (ASCO)
• Holds a PhD in Inorganic Chemistry, providing deep insight into how chemotherapy and targeted drugs work
• Serves as a Professor at Sakarya University Faculty of Medicine training future oncologists

Professor Ozden is a dual-certified specialist in internal medicine and oncology at VM Medical Park Pendik Hospital. He trained at Istanbul University's prestigious English Medical Program.

• Specialises in managing advanced-stage malignancies using systemic therapies
• Focuses on precision medicine for stage 4 respiratory cases
• Completed oncology subspecialty training at Kocaeli University's Faculty of Medicine
• Expert in coordinating multidisciplinary care for complex oncological needs

Professor Gul Alco is a leading radiation oncologist at Medipol Acibadem District Hospital with high-level academic expertise in managing complex malignancies.

• Holds the rank of Professor at Istanbul Medipol University School of Medicine
• Specialises in radiation oncology for treating advanced-stage tumours
• Trained at Istanbul University, one of Turkey's oldest and most prestigious medical schools
• Focuses on precision radiotherapy to target cancer cells while sparing healthy tissue
• Member of key professional bodies dedicated to oncology and radiation research

Associate Professor Nail Paksoy is a highly regarded medical oncologist specializing in advanced lung cancer treatments at Medipol Bahçelievler University Hospital.

• Holds ESMO Board Certification in Medical Oncology, a prestigious European mark of clinical excellence
• Served as a sub-investigator for Pfizer in global trials comparing Lorlatinib to Crizotinib for NSCLC
• Developed published research on identifying mutation markers to improve lung cancer drug effectiveness
• Expertise in immunotherapy and targeted agents like Osimertinib and Alectinib for metastatic cases
• Previously practiced at the Istanbul University Oncology Institute, a major hub for complex cancer care

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Professor Gokhan Haciibrahimoglu is a specialist in thoracic surgical oncology who leads complex lung and tracheal interventions at Medical Park Göztepe Hospital Complex.

• Performs VATS (Video Assisted Thoracoscopic Surgery) – a keyhole approach using small incisions for faster recovery and less pain
• Completed a prestige fellowship in thoracic-vascular surgery and transplantation at the University of Paris-Sud
• Specialises in managing disorders of the mediastinum and pleural diseases involving the lung lining
• Active member of the European Society of Thoracic Surgeons
• Published 13 papers in international journals focusing on chest and lung surgery

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Adnan Sayar specialise in robotic and thoracoscopic surgery for complex lung cancers at Liv Hospital Ulus.

• Performs minimally invasive surgery using tiny incisions for faster recovery and less pain
• Expert in trachea surgery and managing advanced pleural diseases in the lungs
• Specialises in lung biopsies to ensure accurate diagnosis for staged treatment
• Trained at the prestigious Istanbul University Faculty of Medicine

Associate Professor Duygu Derin is a leading medical oncologist at Liv Hospital Ulus with significant expertise in managing advanced-stage lung tumours.

• Specialises in complex chemotherapy and targeted drug protocols for stage 4 cases
• Member of the European Society for Medical Oncology (ESMO)
• Published 30+ scientific papers on improving malignancy treatment outcomes
• Trained at Istanbul University Faculty of Medicine – one of Turkey's oldest medical schools
• Expert in multidisciplinary care for aggressive lung and gastrointestinal cancers

1. Medical Interests and Activities 
2. • Lung Cancer (Postdoctoral fellowship, MD Anderson Cancer Center, Houston, TX, USA)
3. • Interventional Bronchoscopy (Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA)
4.  
5. Education and Experience 
6. • Department of Thoracic Diseases, Liv Hospital, Ulus
7. • Faculty of Medicine, İstanbul Bilim University
8. • Ministry of Health Süreyyapaşa Thoracic Diseases Training and Research Hospital
9. • Faculty of Medicine, Marmara University Memberships
10. • IASLC (International Association for the Study of Lung Cancer)
11. • ACCP (American College of Chest Physicians)
12. • TAKD (Turkish Lung Cancer Society) (Executive Board Member)
13. • TTD (Turkish Thoracic Society)
14. • TÜSAD (Turkish Respiratory Research Society)
15.  
16. Memberships 
17. • IASLC (International Association for the Study of Lung Cancer) 
18. • ACCP (American College of Chest Physicians) 
19. • TAKD (Turkish Lung Cancer Society) (Executive Board Member) 
20. • TTD (Turkish Thoracic Society) 
21. • TÜSAD (Turkish Respiratory Research Society) 
22.  
23. Researches and Publications 
24. • International: 48 
25. • National: 60 
26. • Authorship for Books and Book Chapters at National Level: 4 
27. • Medical Fellowship, TEV Orhan Birman, MD 1998 
28. • “Fellow in American College of Chest Physicians” Title, 2009 

Professor Didem Tastekin is a multi-award-winning oncologist who leads medical oncology at Biruni University Hospital, specialising in complex, intensive cancer cases.

• Recognised as the 2018 Best Researcher of the Year at the Istanbul University Oncology Institute
• Received the TUBITAK Incentive Award for her contributions to cancer research
• Holds double residencies in internal medicine and medical oncology
• Active member of the American Society of Clinical Oncology (ASCO)
• Specialises in managing late-stage cases with tailored drug therapies

Professor Engin is a leading radiation oncologist who completed a post-doctoral fellowship in thermoradiotherapy at Thomas Jefferson University in the United States.

• Specialises in treating advanced-stage tumours using precise radiation delivery
• Director of Oncological Sciences at Medicana Bursa Hospital
• Former Chairman of Radiation Oncology at Uludağ University Medical College
• Received a research scholarship from the US National Cancer Institute (NCI)
• Expert in thermoradiotherapy, which uses heat to make cancer cells more sensitive to radiation

Associate Professor Emrah Eraslan gained his specialist oncology credentials at the Dr Abdurrahman Yurtaslan Ankara Oncology Hospital, a major Turkish cancer centre. He focuses on complex medical oncology cases at Koru Ankara Hospital.

• Specialises in systemic therapies for advanced lung and breast cancers
• Uses targeted drug therapy and immunotherapy to manage stage 4 tumours
• Associate Professor recognized for ongoing research and clinical publications
• Completed dual specialisation in internal medicine and medical oncology
• Experienced in managing gastrointestinal and urological cancers alongside lung cases